D. E. Shaw & Co., Inc. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$4,523,980
-43.0%
5,106,072
+1.0%
0.01%
-44.4%
Q3 2022$7,939,000
-32.8%
5,056,963
-14.0%
0.01%
-35.7%
Q2 2022$11,822,000
-29.9%
5,881,402
-18.8%
0.01%
-12.5%
Q1 2022$16,874,000
+48.3%
7,241,891
+195.9%
0.02%
+77.8%
Q4 2021$11,378,000
-49.5%
2,447,050
-17.1%
0.01%
-55.0%
Q3 2021$22,530,000
+28.4%
2,952,835
+63.1%
0.02%
+33.3%
Q2 2021$17,542,000
+408.0%
1,810,369
+333.6%
0.02%
+400.0%
Q1 2021$3,453,000
+52.2%
417,505
+25.6%
0.00%
+50.0%
Q4 2020$2,269,000
-68.5%
332,338
-48.5%
0.00%
-71.4%
Q3 2020$7,196,000
+759.7%
645,407
+384.4%
0.01%
+600.0%
Q2 2020$837,000
+124.4%
133,238
-34.2%
0.00%0.0%
Q1 2020$373,000
-80.8%
202,519
-64.8%
0.00%
-50.0%
Q4 2019$1,947,000
+1148.1%
576,145
+689.6%
0.00%
Q3 2019$156,000
-51.9%
72,971
+7.1%
0.00%
Q1 2019$324,000
-84.9%
68,126
-92.4%
0.00%
-100.0%
Q4 2018$2,145,000
-45.0%
894,000
+0.8%
0.00%
-40.0%
Q3 2018$3,901,000
-46.5%
886,616
-12.5%
0.01%
-50.0%
Q2 2018$7,293,000
+101.3%
1,012,823
+44.0%
0.01%
+100.0%
Q1 2018$3,623,000
+8526.2%
703,372
+6294.3%
0.01%
Q4 2017$42,000
-89.8%
11,000
-77.5%
0.00%
-100.0%
Q3 2015$411,00048,9720.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders